Infantile neuroblastoma is a rare but significant pediatric malignancy arising from neural crest cells. This case report presents the diagnosis, management and prognosis of a 14-month-old male infant
with that of noncancerous patients. Patients and Methods: A prospective study conducted on 54 pediatric patients with cancer during their treatment with chemotherapy that developed RT-PCR approved COVID ... slightly…
orbital area (33%). IHC aided the confirmation of our diagnoses. CONCLUSION: Paranasal malignancy in the pediatric population often presents with non-specific symptoms, and high index of suspicion along with ... scan is…
services. Methods and Results: We retrospectively reviewed all the patients with different types of pediatric malignancies diagnosed with Covid-19 infection from January 2020 to March 2021, from both inpatient
initiation of olanzapine. Symptoms were most consistent with Neuroleptic Malignant Syndrome (NMS). Neuroleptic Malignant Syndrome (NMS) a potentially fatal neurologic emergency generally precipitated by the use of…
Background: Rare malignant tumors (RMT) make up 10% of all cancer in the pediatric age. The national and international cooperative projects will allow to understand their biology and improve
pediatric patients with differing types of malignancies. Methods: Retrospective review of pediatric patients with hematologic malignancy, solid tumor, or status post autologous or allogeneic hematopoietic stem cell…
This compilation highlights recent advancements in pediatric hematology, addressing malignancies, genetic blood disorders, anemias, bleeding disorders, and transfusion medicine. It emphasizes the evolving roles of…
During the past decades, significant advances have been made in treatment of pediatric malignancies, with more than 80% of children being cured in most developed countries. Therapy responsible for this ... months to…
found that at least one of CCND1, CDK4 or CDK6 was overexpressed in six malignant pediatric brain tumors, including GBMs, anaplastic astrocytomas, medulloblastomas, AT/RTs, ependymomasa and PNETs. Using CDK4…
Kids with cancer (PIP-seq) project has shown that a significant percentage of pediatric malignancies arise because of genetic predisposition. We can consider cancer predisposition as a specialized case ... potentially…
This article will focus on basic concepts in the development of new agents for pediatric malignancies and future directions, while considering the limitations we have today and the lessons ... alternative end points…
patients’ condition in about 30 percent of the cases and changed clinical management of pediatric malignancies in about 20 percent of our patients. The fact that a large percentage
cell Acute Lymphoblastic Leukemia (T-ALL) is a rare and aggressive malignancy, accounting for 12-15% of pediatric ALL cases. Despite advancements in treatment, relapse rates remain high (~20%). Prognosis